Drug Type Small molecule drug |
Synonyms Mycobactovir |
Target |
Action inhibitors |
Mechanism Chitin synthase inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC11H7Cl2N3NaO3 |
InChIKeyOYJVGCCYATVFOR-UHFFFAOYSA-N |
CAS Registry864816-03-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gingivitis | Phase 2 | - | - | - |
Periodontitis | Phase 2 | - | - | - |
Candidiasis, Vulvovaginal | Preclinical | Europe | 16 May 2018 | |
Dermatomycoses | Preclinical | Russia | 21 Aug 2017 | |
Mycoses | Preclinical | Russia | 13 Feb 2016 | |
Candidiasis | Preclinical | Russia | - | |
Candidiasis | Preclinical | United States | - | - |
Cryptococcosis | Preclinical | United States | - | |
Pneumonia | Preclinical | Russia | - | |
Pneumonia | Preclinical | United States | - | - |